KI

Kravis Investment Partners

North America, New York, United States, New York

Description

Kravis Investment Partners

Investor Profile

Kravis Investment Partners has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series D (25%)
  • Series B (25%)

Country Focus

  • United States (50%)
  • India (50%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Apps
  • Banking
  • Finance
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kravis Investment Partners frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 2
OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Uncorrelated Ventures
Europe, England, United Kingdom, London
Co-Investments: 2
Taiho Ventures
North America, California, United States, California City
Co-Investments: 2
Snow Leopard Technology Ventures
Asia, Maharashtra, India, Pune
Co-Investments: 2
Altara Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
The Column Group
North America, California, United States, San Francisco
Co-Investments: 2
Foresite Capital
North America, California, United States, San Francisco
Co-Investments: 2
Memorial Sloan - Kettering Cancer Center
North America, New York, United States, New York
Co-Investments: 2
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 2

What are some of recent deals done by Kravis Investment Partners?

Stashfin

New Delhi, Delhi, India

StashFin is a neo-banking platform with a mission to deliver seamless, transparent, and efficient financial services to everyone.

AppsBankingFinanceFinancial ServicesFinTech
Series CJun 21, 2022
Amount Raised: $70,000,000
Stashfin

New Delhi, Delhi, India

StashFin is a neo-banking platform with a mission to deliver seamless, transparent, and efficient financial services to everyone.

AppsBankingFinanceFinancial ServicesFinTech
Series BApr 2, 2021
Amount Raised: $40,000,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series DAug 9, 2019
Amount Raised: $55,000,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series CFeb 21, 2018
Amount Raised: $50,000,000